|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-1-3
|
|
pubmed:abstractText |
Slow-release (SR) lanreotide is a long-acting somatostatin analog that has been developed in order to overcome the inconvenience of multiple daily subcutaneous injections of octreotide, required for metabolic control in acromegaly. Lanreotide SR has been found to be well tolerated and effective in reducing GH and IGF-I levels but clinical data are still limited compared with those with subcutaneous octreotide treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0804-4643
|
|
pubmed:author |
pubmed-author:AbtSS,
pubmed-author:AlbaniGG,
pubmed-author:BexMM,
pubmed-author:GianolaDD,
pubmed-author:LegrosJ JJJ,
pubmed-author:MaiterDD,
pubmed-author:MockelJJ,
pubmed-author:MontiniMM,
pubmed-author:PaganiGG,
pubmed-author:PaganiM DMD,
pubmed-author:PedroncelliA MAM,
pubmed-author:PoppeKK,
pubmed-author:VandewegheM VMV,
pubmed-author:VerhelstJ AJA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
143
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
577-84
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11078980-Acromegaly,
pubmed-meshheading:11078980-Adult,
pubmed-meshheading:11078980-Aged,
pubmed-meshheading:11078980-Aged, 80 and over,
pubmed-meshheading:11078980-Delayed-Action Preparations,
pubmed-meshheading:11078980-Female,
pubmed-meshheading:11078980-Hormone Antagonists,
pubmed-meshheading:11078980-Human Growth Hormone,
pubmed-meshheading:11078980-Humans,
pubmed-meshheading:11078980-Insulin-Like Growth Factor I,
pubmed-meshheading:11078980-Male,
pubmed-meshheading:11078980-Middle Aged,
pubmed-meshheading:11078980-Octreotide,
pubmed-meshheading:11078980-Peptides, Cyclic,
pubmed-meshheading:11078980-Pituitary Neoplasms,
pubmed-meshheading:11078980-Somatostatin
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients.
|
|
pubmed:affiliation |
Department of Endocrinology, Middelheim Ziekenhuis Antwerpen, Belgium. johan.verhelst@ocmw.antwepen.be
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
